Atossa Genetics Inc. Announces Proposed Public Offering of Common Stock
Atossa Genetics announced that it intends to offer for sale shares of its common stock in an underwritten public offering. The company intends to use the net proceeds from this offering for working capital and to fund other general corporate purposes, including funding the costs of clinical trials. August 30, 2016